Welcome to the IPVC 2021 Conference Program Scheduling.
The meeting will officially run on Toronto Local Time (GMT-5)

To convert the meeting times to your local time click here

Please note that the viewing of the sessions cannot be accessed from this Conference calendar.
All sessions will be available via the Main Lobby on the Virtual Platform.

   

 - Live Sessions   - Pre-Recorded   - Pre-Recorded with Live Q&A

610 Presentations

Sort By Relevance

DIFFERENTIAL EXPRESSION OF LONG NONCODING RNA HOTAIR AS A CANDIDATE BIOMARKER FOR SCREENING OF CERVICAL CANCER PRECANCEROUS LESIONS (ID 20)

Presenter
Lecture Time
06:55 AM - 07:00 AM

IMPLEMENTATION RESEARCH EVIDENCE TO FIND OUT THE SOLUTION FOR CHALLENGES IN CERVICAL CANCER SCREENING FOR THE IMMIGRANT POPULATION IN TORONTO (ID 25)

Presenter
Lecture Time
07:30 AM - 07:35 AM

HIGH-RISK HPV, PRECANCEROUS LESIONS AND CANCER IN ANAL CONDYLOMAS: SYSTEMATIC REVIEW AND META-ANALYSIS. (ID 33)

Presenter
Lecture Time
07:10 AM - 07:15 AM

EFFECT OF INTRODUCING HUMAN PAPILLOMAVIRUS GENOTYPING INTO REAL-WORLD SCREENING ON CERVICAL CANCER SCREENING IN CHINA: A RETROSPECTIVE POPULATION-BASED COHORT STUDY (ID 44)

Presenter
Lecture Time
07:00 AM - 07:05 AM

PATTERN OF HUMAN PAPILLOMAVIRUS INFECTION AND GENOTYPES AMONG NIGERIAN WOMEN FROM 2000 TO 2020: A SYSTEMATIC REVIEW (ID 61)

Presenter
Lecture Time
06:25 AM - 06:30 AM

UNDERSTANDING THE IMPACT OF THE HUMAN PAPILLOMAVIRUS VACCINE ON CERVICAL PREMALIGNANT LESIONS IN URBAN AND RURAL AREAS IN TENNESSEE, 2008-2018 (ID 66)

Presenter
Lecture Time
06:20 AM - 06:25 AM

PERCEPTION AND ATTITUDES AMONG FAMILIES TOWARD THE HUMAN PAPILLOMA VIRUS (HPV) VACCINE : A NEWLY DISCOVERING CONCEPT IN THE STATE OF QATAR (ID 68)

Presenter
Lecture Time
06:25 AM - 06:30 AM

HOW DOES THE TRANSITION TO PRIMARY HPV SCREENING IMPACT COLPOSCOPY: FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEMENTATION AND EXPERIENCES STUDY (STORIES). (ID 70)

Presenter
Lecture Time
06:35 AM - 06:40 AM

MONITORING THE HPV VACCINATION PROGRAM IMPACT ON EARLY AND INTERMEDIATE HPV TYPE-SPECIFIC OUTCOMES AMONG WOMEN IN THE UNITED STATES (ID 74)

Presenter
Lecture Time
06:20 PM - 06:32 PM

USEFULNESS OF E7 MRNA IN HPV16-POSITIVE WOMEN TO PREDICT THE RISK OF PROGRESSION TO HSIL/CIN2+ (ID 76)

Presenter
Lecture Time
06:28 PM - 06:40 PM

POTENTIAL ADVERSE EFFECTS OF HPV-BASED CERVICAL CANCER SCREENING - RESULTS OF AN INTERIM ANALYSIS OF THE HIPPO STUDY IN POLAND (ID 77)

Presenter
Lecture Time
11:58 AM - 12:10 PM

HUMAN PAPILLOMAVIRUS (HPV) VACCINE IMPACT AMONG FEMALES AGED 14-24 YEARS IN THE UNITED STATES, NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY, 2003-2018 (ID 91)

Presenter
Lecture Time
06:32 PM - 06:44 PM